Skip to main content

Publication on MS Antigen Specific Treatment

March 10, 2017

In our latest Ainslie Lab publication we identify the presence of T-regulatory cells that are specific for peptides in myelin (the proteins that coat nerve cells) when we deliver rapamycin and peptide in our Ace-DEX microparticles.

Dr. Guysh gives division seminar

February 6, 2017

Ainslie Lab Post Doc Elizabeth Gurysh is presenting a seminar for UNC Eshelman School of Pharmacy titled “Drug Loaded Acetalated Dextran Scaffold for Treatment of Recurrent Glioblastoma” today at 12:30 in Kirkland Auditorium.

Last MS publication in collaboration with Guerau-de-Arellano Lab

January 17, 2017

The Ainslie Lab has a new publication in collaboration with Dr. Mireia Guerau-de-Arellano at Ohio State. Mirea’s lab identified PRMT’s potential role as a therapy-target for the treatment of multiple sclerosis and perhaps other autoimmune diseases. Also, the beautiful docking … Read more

Ac-DEX Reveiw by Ainslie Lab

December 29, 2016

We have published a comprehensive review of Acetalated Dextran in ACS Chemical Reviews. It covers the more than 40 publications that use Ac-DEX since the discovery of the biopolymer in 2008. http://pubs.acs.org/doi/ipdf/10.1021/acs.chemrev.6b00532

Ainslie Lab’s work the cover of Carolina Scientific

December 19, 2016

The Ainslie Lab’s work is the focus of the Carolina Scientific’s cover this semester. Carolina scientific is an undergraduate run science research magazine here at UNC. Check it out! https://issuu.com/uncsci/docs/compilationfinaledited